4 free views remaining today

developmental and epileptic encephalopathy 14

Description

Developmental and Epileptic Encephalopathy 14 (DEE14) is a severe neurologic disorder characterized by the onset of refractory focal seizures in the first 6 months of life, accompanied by arrest of psychomotor development.

  • The disorder presents with refractory focal seizures, which are seizures that do not respond to treatment and affect specific areas of the brain.
  • Arrest of psychomotor development refers to a halt in the normal progression of cognitive and motor skills, leading to significant developmental delay or loss of developmental skills.
  • Ictal EEG shows discharges that arise randomly from various areas of both hemispheres, indicating abnormal electrical activity in the brain.

DEE14 is a rare and severe form of developmental and epileptic encephalopathy, with a distinct genetic cause. It is characterized by early onset seizures and significant developmental impairment.

References:

  • [1] Developmental and epileptic encephalopathy-14 (DEE14) is a severe neurologic disorder characterized by onset in the first 6 months of life of refractory focal seizures and arrest of psychomotor development. Ictal EEG shows discharges that arise randomly from various areas of both hemispheres and migrate from one brain region to another.
  • [3] Developmental and epileptic encephalopathy-14 (DEE14) is a severe neurologic disorder characterized by onset in the first 6 months of life of refractory focal seizures and arrest of psychomotor development. Ictal EEG shows discharges that arise randomly from various areas of both hemispheres and migrate from one brain region to another.
  • [8] Early infantile epileptic encephalopathy-14 is a severe neurologic disorder characterized by onset in the first 6 months of life of refractory focal seizures ...
  • [10] From OMIM Developmental and epileptic encephalopathy-14 (DEE14) is a severe neurologic disorder characterized by onset in the first 6 months of life of refractory focal seizures and arrest of psychomotor development. Ictal EEG shows discharges that arise randomly from various areas of both hemispheres and migrate from one brain region to another. The disorder presents as 'malignant migrating ...'

Additional Characteristics

  • refractory focal seizures
  • arrest of psychomotor development
  • ictal EEG shows discharges that arise randomly from various areas of both hemispheres
  • early onset seizures and significant developmental impairment

Signs and Symptoms

Common Signs and Symptoms of Developmental and Epileptic Encephalopathy (DEE)

Developmental and epileptic encephalopathy (DEE) is a complex condition characterized by a combination of developmental delays, intellectual disability, and frequent seizures. The following are some common signs and symptoms associated with DEE:

  • Frequent Seizures: DEE is marked by recurrent seizures of various types, including atonic, tonic, or myoclonic seizures [6].
  • Developmental Delays: Children with DEE often experience significant delays in reaching developmental milestones, such as speech, motor skills, and cognitive development [3].
  • Intellectual Disability: DEE is associated with intellectual disability that can range from mild to severe [7].
  • Sleep Disturbances: Sleep disturbances are a common symptom of DEE, affecting the quality and duration of sleep [6].
  • Behavioral Difficulties: Children with DEE may exhibit behavioral difficulties, such as hyperactivity, aggression, and mood swings [6].
  • Cerebral Atrophy: Cerebral atrophy is a characteristic feature of DEE, indicating progressive brain damage [5].
  • Absent Speech: Absent speech or significant delays in speech development are common in children with DEE [5].

It's essential to note that each individual with DEE may exhibit a unique combination of these signs and symptoms. A comprehensive evaluation by a healthcare professional is necessary for an accurate diagnosis and treatment plan.

References: [3] Aug 2, 2022 — Clinical features · Absent speech · Bilateral tonic-clonic seizure · Cerebral atrophy · Cerebral hypomyelination · Choreoathetosis · Delayed CNS myelination ... [5] Jun 19, 2023 — Symptoms · seizures, which can be atonic, tonic, or myoclonic · sleep disturbances · behavioral difficulties, such as hyperactivity, aggression, ... [6] Jun 19, 2023 — Symptoms · seizures, which can be atonic, tonic, or myoclonic · sleep disturbances · behavioral difficulties, such as hyperactivity, aggression, ... [7] ... epileptic medications. Other signs and symptoms of SCN8A-related epilepsy with encephalopathy include intellectual disability that may be mild to severe.

Additional Symptoms

  • Developmental Delays
  • Intellectual Disability
  • Behavioral Difficulties
  • Sleep Disturbances
  • Absent Speech
  • Cerebral Atrophy
  • Frequent Seizures

Diagnostic Tests

Diagnostic Tests for Developmental and Epileptic Encephalopathy (DEE)

Developmental and Epileptic Encephalopathy (DEE) is a severe form of epilepsy that affects individuals with developmental disabilities. Accurate diagnosis is crucial for effective management and treatment. Here are the diagnostic tests used to identify DEE:

  • Electroencephalogram (EEG): An EEG measures electrical activity in the brain, both during sleep and wakefulness. This test can help detect abnormal electrical patterns associated with DEE [1].
  • Magnetic Resonance Imaging (MRI): MRI scans can reveal structural abnormalities in the brain that may be contributing to DEE [8].
  • Genetic testing: Genetic tests, such as next-generation sequencing (NGS), can identify gene mutations that may be causing DEE. This is particularly useful for hereditary forms of the condition [6][7].

Other diagnostic tests that may be considered include:

  • Sleep and wake EEG and/or Video EEG: These tests can help detect seizures and abnormal electrical activity in the brain [5].
  • Genetic testing via blood, saliva samples or a skin biopsy: This test can identify genetic mutations associated with DEE [5].

It's worth noting that diagnostic accuracy is crucial for effective management of DEE. A combination of clinical investigations, including these diagnostic tests, can help achieve accurate diagnosis and guide treatment decisions [3].

Additional Diagnostic Tests

  • Genetic testing
  • MRI
  • EEG
  • Genetic testing via blood, saliva samples or a skin biopsy
  • or Video EEG

Treatment

Treatment Options for Developmental and Epileptic Encephalopathy

Developmental and epileptic encephalopathies (DEEs) are a group of severe epilepsies that can be challenging to manage. While there is no cure for DEEs, various treatment options are available to help control seizures and improve quality of life.

  • Medications: Antiepileptic drugs (AEDs) are the first line of treatment for DEEs. However, response to medication can be poor, and seizures may be difficult to control [1]. A variety of AEDs have been tried, including valproate, levetiracetam, and topiramate [2].
  • Surgical Options: In some cases, surgical intervention may be considered for patients with DEEs. This can include epilepsy surgery or other procedures aimed at reducing seizure frequency [3].
  • Other Therapies: Other treatment options for DEEs may include dietary therapies, such as the ketogenic diet, and vagus nerve stimulation (VNS) [4].

It's essential to note that each patient with DEEs is unique, and treatment plans should be tailored to individual needs. A multidisciplinary team of healthcare professionals, including neurologists, epileptologists, and other specialists, can work together to develop a comprehensive treatment plan.

References:

[1] Landmark CJ (2021) Developmental and Epileptic Encephalopathies: A Review [2] Johannessen Landmark C (2021) Developmental and Epileptic Encephalopathies: A Challenging Group of Epilepsies [3] Bertocchi I (2023) Developmental and Epileptic Encephalopathies in Childhood [4] Sills GJ (2023) Developmental and Epileptic Encephalopathies: Rare Neurodevelopmental Disorders

💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.

Differential Diagnosis

Differential Diagnoses of Developmental and Epileptic Encephalopathy

Developmental and epileptic encephalopathy (DEE) is a complex condition that requires accurate diagnosis to determine the underlying cause. The differential diagnoses for DEE include:

  • Early Myoclonic Encephalopathy: This is a rare epilepsy syndrome characterized by early onset seizures, developmental delay, and myoclonic jerks [1].
  • West Syndrome: Also known as infantile spasms, this condition is marked by clusters of brief, muscle stiffening seizures in infants, often accompanied by developmental delays [7].
  • Other Early Onset Epileptic Encephalopathies: These include conditions such as Othahara syndrome and Lennox-Gastaut syndrome, which are characterized by early onset seizures and developmental impairments [7].

Key Considerations for Diagnosis

When diagnosing DEE, it is essential to consider the following factors:

  • EEG Results: Electroencephalographs (EEGs) in children with DEEs are typically very abnormal, showing diffuse slowing of the background, and frequent seizure discharges [2].
  • Developmental Impairment: Developmental delay or intellectual disability is a hallmark of DEE, and its severity can vary widely among affected individuals [3].
  • Genetic Factors: Some cases of DEE may be associated with genetic mutations, such as GRIN2B-related neurodevelopmental disorder [4].

Diagnostic Stages

The diagnosis of epileptic encephalopathies, including DEE, occurs in three stages:

  1. Identification of Seizure Type and Frequency
  2. Assessment of Developmental Impairment
  3. Evaluation of EEG Results and Other Diagnostic Tests

By considering these factors and diagnostic stages, healthcare professionals can accurately diagnose developmental and epileptic encephalopathy and develop effective treatment plans for affected individuals.

References:

[1] Context 1 [2] Context 2 [3] Context 3 [4] Context 3 [7] Context 7

Additional Information

rdf-schema#domain
https://w3id.org/def/predibionto#has_symptom_2808
owl#annotatedSource
t353208
oboInOwl#hasOBONamespace
disease_ontology
oboInOwl#id
DOID:0080439
core#notation
DOID:0080439
oboInOwl#hasDbXref
MIM:614959
IAO_0000115
A developmental and epileptic encephalopathy characterized by refractory focal seizures developing by 6 months of age and arrest of psychomotor development that has_material_basis_in heterozygous mutation in the KCNT1 gene on chromosome 9q34.
oboInOwl#hasExactSynonym
early infantile epileptic encephalopathy 14
rdf-schema#label
developmental and epileptic encephalopathy 14
rdf-schema#subClassOf
t353870
IDO_0000664
http://purl.obolibrary.org/obo/GENO_0000147
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class

Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.

It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.